
Berkshire shares dip after earnings decline, lack of buybacks disappoint investors
The Omaha-based giant saw operating earnings including those from its insurance and railroad businesses decline dip 4% year over year to $11.16 billion in the second quarter. While railroad, energy, manufacturing, service and retailing all reported higher profits from a year ago, a drop in insurance underwriting dragged down overall results.
Class A and B shares of Berkshire both declined about 1% in premarket trading Monday following the results. The stock has fallen about 12% from its all-time high in early May right before the 94-year-old Buffett announced that Greg Abel is taking over as CEO at the end of 2025.
A move that caught many by surprise was a big write-down for Berkshire's underperforming Kraft Heinz stake. The conglomerate for the first time recorded a loss of $3.8 billion from its 27% Kraft Heinz stake. The move came as reports emerged that the consumer goods giant has been eyeing a spinoff of its grocery business. Two Berkshire executives resigned as directors from Kraft Heinz's board in May.
"The investment had been carried on Berkshire's books for more than its market value for some time," said Bill Stone, CIO of The Glenview Trust Company and a Berkshire shareholder. "Buffett has long acknowledged that he paid too much for Kraft Heinz, especially in light of the increased competition in the branded food category."
Buffett's cash hoard of $344.1 billion remained near a record high. Berkshire was a net seller of stocks for a 11th quarter in a row, dumping $4.5 billion in equities in the first six months of 2025.
The conglomerate also didn't repurchase any stock in the first half of 2025 and through July 21 even as shares suffered a sizable correction.
"While we believe Mr. Abel will build credibility with investors over time, we think near-term catalysts for BRK are increased investment activity, a potential large acquisition, and share repurchases," Kyle Sanders, analyst at Edward Jones, said in a note. "None of those happened this quarter, which we view as somewhat disappointing."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
19 minutes ago
- Yahoo
Heartflow raises $316.7 million in US IPO as medtech listings attempt comeback
By Ateev Bhandari and Pritam Biswas (Reuters) -Medical technology firm Heartflow said on Thursday it had raised $316.7 million in its U.S. initial public offering, setting the stage for its Nasdaq debut in another test of investor appetite for medical tech companies. The Mountain View, California-based company sold 16.67 million shares at $19 each, compared with a targeted range of $17 to $18 apiece. It upsized its offering and raised the proposed range earlier this week reflecting strong demand. The IPO valued the company at $1.54 billion. U.S. IPOs have picked up pace in a much-awaited recovery, as solid tech earnings and progress on trade deals have helped restore investor confidence. Strong recent debuts mark a reversal from early April, when uncertainty around U.S. President Donald Trump's tariffs paused dealmaking. Heartflow's stock will begin trading on the Nasdaq on Friday under the "HTFL" ticker symbol. The closing of the offering is expected on August 11. J.P. Morgan, Morgan Stanley and Piper Sandler are the lead underwriters for the offering. Following software firm Figma's blowout debut last week, analysts expect companies with a compelling growth story to be welcomed by the public markets. "We expect Heartflow to be well received at launch, especially following Figma's breakout success, which has helped reset sentiment toward high-growth names," IPOX CEO Josef Schuster said. Bain Capital-backed Heartflow leverages AI to create 3D models of the heart via a single specialized scan, improving detection and treatment of coronary artery disease (CAD). As AI gains widespread acceptance, companies embedding it into workflows for meaningful use cases are catching investor attention, with the technology powering gains across various Big Tech businesses. Heartflow's revenue grew 39% for the quarter ended March 31 from a year earlier. Its platform to detect CAD was used in 132,000 patients in 2024. Sign in to access your portfolio

Los Angeles Times
an hour ago
- Los Angeles Times
Russian superyacht, with helideck and marble fireplace, was seized. Now you can bid on it
The Russian oligarch billionaire lifestyle can be yours for the potentially low, low price of tens of millions of dollars, courtesy of the U.S. federal government. The National Maritime Services, working on behalf of the U.S. Marshals Service, is auctioning off a superyacht, the $300-million-plus Amadea, which currently sits in a San Diego harbor, with a bid deposit starting at $10 million. Florida-based Fraser Yachts, the auction's promotional agents, described the prize 'as one of the most comprehensively equipped yachts in her class.' The 348-foot-long ship was built in 2017 and can comfortably host 16 guests in eight luxurious staterooms. An additional 21 cabins can house a professional crew of up to 36 workers. One of the ship's jewels is a glass elevator that serves all decks, while a second lift is available for crew. The yacht includes a glass-edged mosaic pool with submerged bar stools, and an outdoor bar area surrounded by sun pads (cushioned areas for perfecting your tan). The ship's main salon showcases a piano and marble fireplace. The yacht was designed by Espen Øino, the acclaimed Norwegian designer and naval architect, while its decadent interiors were created by designer François Zuretti. The ship has an ocean-crossing range of 8,000 nautical miles at a speed of 13 knots. For late-arriving quests, the Amadea also boasts a helideck. The U.S. Justice Department maintained in a 2023 civil forfeiture complaint that Russian oligarch Suleiman Kerimov was the ship's owner. Kerimov took possession of the vessel sometime around 2021, though his transactions were cloaked through shell companies, according to the complaint. Kerimov was sanctioned by the U.S. in 2018 and labeled a Specially Designated National for his alleged role in money laundering related to the purchase of French villas. The U.S. Department of the Treasury's Office of Foreign Assets Control determined Kerimov was a direct beneficiary of Russian President Vladimir Putin and 'played a key role in advancing Russia's malign activities,' which includes the invasion of Ukraine. The U.S. has said it's working with allies to put pressure on Russian oligarchs, some of whom are close to Putin and have had their yachts seized, to try to compel him to stop the war, the Associated Press reports. The Amadea was seized in Fiji in April 2022 and arrived in San Diego in June that year. The Southern District of New York ruled in March that the Amadea was to be forfeited to the federal government. That decision is being appealed by the man who claims to own the sumptuous vessel — Eduard Khudainatov, the non-sanctioned former chairman of Russian state-controlled oil giant Rosneft, according to the Associated Press. U.S. prosecutors maintain that Khudainatov is a straw owner of the yacht. On July 1, the Marshals Service authorized Fraser Yachts as the promotional agent for the sealed bid auction. The auction is being conducted in U.S. dollars and is running until 11 a.m. on Sept. 10 at The initial deposit necessary to make a bid is $10 million. All bids will remain sealed with the highest bidder winning the yacht. Should multiple participants tie with the top price, each bidder will be given a chance to increase their offering until a winner is determined.

USA Today
an hour ago
- USA Today
FDA issues warning as NuNaturals sweeteners recalled because of mislabeling
Two different recalls of NuNaturals sugar-free products were recently given the second-highest risk warning by the U.S. Food & Drug Administration. NuNaturals, Inc. initiated a voluntary recall for certain lots of its Organic Pure Stevia and Pure Monk Fruit Sweetener for a labeling mishap on July 14. Products labeled as Organic Pure Stevia actually contained Monk Fruit powder, while products labeled as Pure Monk Fruit Sweetener contained Stevia powder. Both recalls were given a Class II risk warning on Aug. 1. NuNaturals recalled a total of 156 bottles, consisting of 78 Organic Pure Stevia bottles and 78 Pure Monk Fruit Sweetener bottles. Both products were sold and distributed to retailers nationwide. It's not immediately clear what led up to the labelling error, or if the recalls impacted any consumers. USA TODAY reached out to the Eugene, Oregon-based company for comment. Here's what to know about the NuNaturals recall, including what to do with affected products. What is a Class II recall? According tothe FDA, a Class II recall denotes a "situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." NuNaturals recall: Affected products, remedy A batch of two different NuNaturals sugar-free sweetener products, including Organic Pure Stevia and Pure Monk Fruit Sweetener, was impacted by the recall, which was initiated on July 14. Relevant information about each product, including best-by dates and universal product codes, is listed below. Organic Pure Stevia - 1 oz: Pure Monk Fruit Sweetener - 0.71 oz: The FDA and NuNaturals, Inc. have yet to offer guidance on what to do with the affected product or products, but USA TODAY has reached out to request clarification.